BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
10 results:

  • 1. Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC.
    Hong SH; Lee YJ; Jang EB; Hwang HJ; Kim ES; Son DH; Park SY; Moon HS; Yoon YE
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203388
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis.
    Sun R; Yan B; Li H; Ding D; Wang L; Pang J; Ye D; Huang H
    Cancer Res; 2023 Oct; 83(19):3192-3204. PubMed ID: 37527336
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
    Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
    Front Immunol; 2022; 13():926461. PubMed ID: 36311770
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.
    Tamukong PK; Kuhlmann P; You S; Su S; Wang Y; Yoon S; Gong J; Figlin RA; Janes JL; Freedland SJ; Halabi S; Small EJ; Rini BI; Kim HL
    Urol Oncol; 2022 Nov; 40(11):495.e1-495.e10. PubMed ID: 35973929
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Safety, efficacy, and mid-term oncological outcomes of computed tomography-guided cryoablation of T1 renal cancer.
    Duus LA; Junker T; Rasmussen BS; Bojsen JA; Pedersen AL; Anthonsen A; Lund L; Pedersen M; Graumann O
    Acta Radiol; 2023 Feb; 64(2):814-820. PubMed ID: 35297745
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.
    Cocco E; Leo M; Canzonetta C; Di Vito S; Mai A; Rotili D; Di Napoli A; Vecchione A; De Nunzio C; Filetici P; Stoppacciaro A
    Clin Epigenetics; 2018; 10():44. PubMed ID: 29632619
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The mutational landscape of chromatin regulatory factors across 4,623 tumor samples.
    Gonzalez-Perez A; Jene-Sanz A; Lopez-Bigas N
    Genome Biol; 2013; 14(9):r106. PubMed ID: 24063517
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
    Pawlus MR; Wang L; Hu CJ
    Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma.
    Zhang Y; Jiang X; Qin X; Ye D; Yi Z; Liu M; Bai O; Liu W; Xie X; Wang Z; Fang J; Chen Y
    Oncogene; 2010 Sep; 29(39):5404-15. PubMed ID: 20603618
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
    Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
    Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.